Morgan Stanley’s AYTU BioPharma AYTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$624 Sell
286
-4
-1% -$9 ﹤0.01% 7403
2025
Q1
$348 Hold
290
﹤0.01% 7413
2024
Q4
$493 Hold
290
﹤0.01% 7344
2024
Q3
$681 Sell
290
-150
-34% -$352 ﹤0.01% 7271
2024
Q2
$1.29K Sell
440
-620
-58% -$1.81K ﹤0.01% 7128
2024
Q1
$3.22K Sell
1,060
-1,740
-62% -$5.29K ﹤0.01% 6989
2023
Q4
$7.95K Buy
2,800
+1,400
+100% +$3.98K ﹤0.01% 6888
2023
Q3
$3.78K Buy
1,400
+960
+218% +$2.59K ﹤0.01% 6979
2023
Q2
$704 Sell
440
-584
-57% -$934 ﹤0.01% 7343
2023
Q1
$2.29K Sell
1,024
-1
-0.1% -$2 ﹤0.01% 7215
2022
Q4
$3.87K Buy
1,025
+1
+0.1% +$4 ﹤0.01% 7217
2022
Q3
$4K Sell
1,024
-250
-20% -$977 ﹤0.01% 7289
2022
Q2
$17K Sell
1,274
-1,287
-50% -$17.2K ﹤0.01% 7040
2022
Q1
$56K Sell
2,561
-6,946
-73% -$152K ﹤0.01% 6646
2021
Q4
$257K Sell
9,507
-9,389
-50% -$254K ﹤0.01% 5928
2021
Q3
$1.09M Buy
18,896
+16,781
+793% +$966K ﹤0.01% 4997
2021
Q2
$212K Buy
2,115
+2,046
+2,965% +$205K ﹤0.01% 5983
2021
Q1
$10K Sell
69
-667
-91% -$96.7K ﹤0.01% 6928
2020
Q4
$87K Buy
736
+693
+1,612% +$81.9K ﹤0.01% 5966
2020
Q3
$10K Sell
43
-17
-28% -$3.95K ﹤0.01% 6267
2020
Q2
$17K Buy
60
+51
+567% +$14.5K ﹤0.01% 6042
2020
Q1
$3K Sell
9
-190
-95% -$63.3K ﹤0.01% 6312
2019
Q4
$39K Buy
+199
New +$39K ﹤0.01% 5926
2019
Q3
Hold
0
6633
2019
Q2
Hold
0
6642
2019
Q1
Hold
0
6590
2018
Q4
Hold
0
6593
2018
Q3
Hold
0
6709
2018
Q2
Hold
0
6662
2018
Q1
Hold
0
6607
2017
Q4
Hold
0
6565